Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 13/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.39 |
| ▸ | KCNAB1 | Q14722 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8337453 | 1.00 | UTS2R (0.55) | UTS2RPKMESR1ESR2SMN1; SMN2 | |
| SCHEMBL6686223 | 0.86 | UTS2R (0.63) | UTS2RPKMSMN1; SMN2 | |
| SCHEMBL6677197 | 0.86 | UTS2R (0.63) | UTS2RPKMSMN1; SMN2 | |
| SCHEMBL6677188 | 0.86 | UTS2R (0.63) | UTS2RPKMSMN1; SMN2 | |
| SCHEMBL6819749 | 0.81 | UTS2R (0.67) | UTS2R | |
| SCHEMBL6824191 | 0.81 | UTS2R (0.67) | UTS2R | |
| SCHEMBL8342356 | 0.80 | UTS2R (0.64) | UTS2R | |
| SCHEMBL8342627 | 0.80 | UTS2R (0.64) | UTS2R | |
| SCHEMBL5834910 | 0.80 | UTS2R (0.71) | UTS2R | |
| SCHEMBL6814887 | 0.80 | UTS2R (0.66) | UTS2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004043369-A2 | SULFONAMIDES | SMITHKLINE BEECHAM CORPORATION (US) | 2004-05-27 | — | — | WO | claimed |
| WO-2004043369-A2 | SULFONAMIDES | SMITHKLINE BEECHAM CORPORATION (US) | 2004-05-27 | — | — | WO | disclosed |